Investigative Radiology 2001: Vol 36 Index

11 Pages·2001·3.1 MB·English

Author Index—Volume 36
A Brehme, U.: see Tepe, G. Denslow, S.: see Bohning, D. E.
Brekenfeld, C., Foert, E., Hundt, W., Kenn, W.., De Ree, J.: see Stolk, J.
Achten, E.: see Sijens, P. E.
Lodeann, K.-P., Gehl, H.-B.: Enhancement of Deurloo, E. E., Gilhuijs, K. G. A., Kool, L. J. S.,
Adam, G.: see Haage, P.
cerebral diseases: How much contrast agent is Muller, S. H.: Displacement of breast tissue
Adams, M. D. see Wible, J. H.. Jr.
enough? Comparison of 0.1, 0.2, and 0.3 and needle deviations during stereotactic pro-
Adams, M. D.: see Ni, Y.
mmol/kg gadoteridol at 0.2 T with 0.1 cedures, 347
Adzamli, K.: see Ni, Y.
mmol/kg gadoteridol at 1.5 T, 266 De Valois, J. C.: see Van Heesewijk, H. P. M.
Albert, A.: see Szapiro, D.
Bremer, C., Kreft, G., Roggan, A., Filler, T., Devoldere, L.: see Idée, J.-M.
Alfke, H.: see Wagner, H.-J.
Reimer, P.: Ex vivo evaluation of novel min- Di Bella, E. V. R., Ross, S. G., Kadrmas, D. J.,
Allder, S. J.: see Martel, A. L.
iaturized laser-induced interstitial thermother- Khare, H. S., Christian, P. E., McJames, S..,
Allkemper, T.: see Maintz, D.
apy applicators for effective small-volume tis- Gullberg, G. T.: Compartmental modeling of
Altan, S. K.: see Karadeniz, Y. M. sue ablation, 327 technetium-99m-labeled teboroxime with dy-
Altinok, D.: see Karadeniz, Y. M.
Breteler, M. M. B.: see Sijens, P. E. namic single-photon emission computed to-
Alvino, S.: see Lorusso, V.
Brossmann, J.: see Ertl-Wagner, B. B. mography: Comparison with static thallium-
Anastasia-Rubino, L.: see Tello, R.
Brossmann, J.: see Miiller-Hiilsbeck, S. 201 in a canine model, 178
Armstrong, M. R.: see Runge, V. M.
Budoff, M. J.: see Lu. B.; Mao, S. Dinkelborg, L. M.: see Tepe, G.
Aronen, H. J.: see Markkola, A. T.
Buecker, A.: see Meyer, J. M. A. Dirksen, A.: see Stolk, J.
Burger, H.: see Meiners, L. C. Doéhmen, S.: see Haage, P.
Burstein, D.: see Gillis, A. Dondelinger, R. F.: see Szapiro, D.
Busch, M.: see Kivelitz, D. Drescher, P.: see Rauch, D.
Bach-Gansmo, T.: see Dupas, B. Bush, H. L., Jr.: see Wang, Y. Duarte, C. G., Zhang, J., Ellis, S.: Review of
Bakhsheshi, H.: see Lu, B.; Mao, S. Bush, H. L., Jr.: see Wecksell, M. B. studies establishing the aging male spontane-
Balédent, O., Henry-Feugeas, M.-C. C., Idy-Per- Butz, B.: see Strotzer, M. ously hypertensive rat as a detector and quan-
etti, I.: Cerebrospinal fluid dynamics and re- tifier of the kidney toxcity of radioconstrast
lation with blood flow: A magnetic resonance C media and other chemicals, 56
study with semiautomated cerebrospinal fluid Duda, S. H.: see Tepe, G.
segmentation, 368 Canet, E.: see Wiart, M. Dupas, B., Pradal, G., Muller, R. N., Bonne-
Baledent, O.: see Henry-Feugeas, M.-C. Casparie, H. W. B. M.: see Van Heesewijk, main, B., Meflah, K., Bach-Gansmo, T.: Hep-
Barco, S. J.: see Wible, J. H., Jr. H. P. M. atocyte-mediated transport to the bile of AMI-
Bares, R.: see Tepe, G. Chambers, J. B.: see Bokor, D. HS, a particulate contrast agent, 509
Barr, R. G.: see Runge, V. M. Chang, K. H.: see Kim, H. J. Durocher, A.: see Labelle, M.
Bashir, A.: see Gillis, A. Chaoui, A.: see Tello, R.
Baumbach, A.: see Tepe, G. Chavez, H. A.: see Toney, G. M.
Becker, M.: see Sayegh, Y. Chenevert, T. L.: see Schoenberg, S. O. E
Behrenbeck, T.: see Gerber, T. C. Cho, B. M.: see Kim, H. J. Eberle, B.: see Kauczor, H.-U.
Belguise-Valladier, P.: see Lewin, M. Choi, B. L: see Kim, A. Y. Ellis, S.: see Duarte, C. G.
Benderbous, S.: see Idée, J.-M. Choi, D.: see Kwak, B. K. Ennker, J.: see Winterer, J. T.
Berger. B. L.: see Runge, V. M. Christian, P. E.: see Di Bella, E. V. R. Eracleous, E.: see Papanikolaou, N.
Berthezene, Y.: see Wiart, M. Chung, J. W.: see Kwak, B. K. Ertl-Wagner, B. B., Stibler, A., Brossmann, J.,
Bewig, B.: see Miiller-Hiilsbeck, S. Claussen, C. D.: see Tepe, G. Trudell, D., Resnick, D.: Assessment of the
Bigler, E. D., Tate, D. F.: Brain volume, intra- Clément, O.: see Lewin, M. position of the distal portion of the ulna in
cranial volume, and dementia, 539 Colosimo, C., Ruscalleda, J.. Korves, M., La lateral projection radiographs of the wrist:
Bittoun, J.: see Henry-Feugeas, M.-C. Ferla, R., Wool, C., Pianezzola, P., Kirchin, Analysis of the influence of pronation-supina-
Boehm, T., Hochmuth, A., Malich, A., Reichen- M. A. : Detection of intracranial metastases: A tion and flexion-extension on the pisoscaphoid
bach, J. R., Fleck, M., Kaiser, W. A.: Con- multicenter, intrapatient comparison of gado- and the ulnotriquetral distances: A cadaver
trast-enhanced near-infrared laser mammogra- benate dimeglumine-enhanced MRI with study, 612
phy with a prototype breast scanner: rountinely used contrast agents at equal dos- Even-Sapir, E.: see Metser, U.
Feasibility study with tissue phantoms and age, 72
preliminary results of imaging experimental Copoix, F.: see Laurent, S. F
tumors, 573 Cornu, P.: see Henry-Feugeas, M.-C.
Boehm, T., Malich, A., Reichenbach, J. R., Corot, C.: see D’Anglemont De Tassigny; Idée, Felix, R.: see Stroszezynski, C.
Fleck, M., Kaiser, W. A.: Percutaneous radio- J.-M.; Port, M.; Wiart, M. Fenlon, H.: see Tello, R.
frequency (RF) thermal ablation of rabbit tu- Cresens, E.: see Ni, Y. Feuerbach, S.: see Seitz. J.
mors embedded in fat: A model for RF abla- Cuénod, C.-A.: see Lewin, M. Feuerbach, S.: see Strotzer, M.
tion of breast tumors, 480 Czervionke, L. F.: see Runge, V. M. Filler, T.: see Bremer, C.
Bohnemann, L.: see Rauch, D. Fischbach, R.: see Maintz, D.
Bohning, D. E., Lomarev, M. P., Denslow, S.., Fleck, M.: see Boehm, T.
D
Nahas, Z., Shastri, A., George, M. S.: Feasi- Flohr, T.: see Wildberger, J. E.
bility of vagus nerve stimulation-synchro- Damilakis, J.: see Perisinakis, K. Foert, E.: see Brekenfeld, C.
nized blood oxygenation level-dependent D’ Anglemont De Tassigny, A., Idée, J.-M., Co- Fouillet, X.: see Katayama, H.
functional MRI, 470 rot, C.: Comparative effects of ionic and non- Fouillet, X.: see Sayegh, Y.
Bokor, D., Chambers, J. B., Rees, P. J., Mant. ionic iodinated low-osmolar contrast media on Friedman, Z.: see Metser, U.
T. G. K., Luzzani, F., Spinazzi, A.: Clinical platelet function with the PFA-100™ (platelet Frigeni, V., Miragoli, L., Grotti, A., Lorusso, V.:
safety of SonoVue™, a new contrast agent for function analyzer), 276 Comparative study between gadobenate dime-
ultrasound imaging, in healthy volunteers and Davies, A.: see Katayama, H. glumine gadobutrol in rats with brain isch-
in patients with chronic obstructive pulmo- De Baere, T.: see Lassau, N. emia, 561
nary disease, 104 DeCarvalho, V. L.: see Tello, R. Frigeni, V., Miragoli, L., Grotti, A., Lorusso, V.:
Bonneau, M.: see Pelage, J.-P. De Groot, J. C.: see Sijens, P. E. Neurotolerability of contrast agents in rats
Bonnemain, B.: see Dupas, B. De Kort, G. A. P.: see Meiners, L. C. with brain ischemia induced by transient mid-
Bonnemain, B.: see Idée, J.-M. Delay. G. S.: see Martel, A. L. dle cerebral artery occlusion: EEG evaluation,
Bonnemain, B.: see Port, M. De Leeuw, F. E.: see Sijens, P. E. 1
Boulanger, Y.: see Labelle, M. Dencausse, A.: see Idée, J.-M. Frija, G.: see Lewin, M.
Bourbouze, R.: see Idée, J.-M. Dencausse, A.: see Port, M. Frokiaer, J.: see Rawashdeh, Y. F.
Bourrinet, P.: see Idée, J.-M. Den Heijer, T.: see Sijens, P. E. Furuta, W.: see Tominaga, K.
INVESTIGATIVE RADIOLOGY December 2001 Vol. 36
G O., Cornu, P., Lejay, H., Bittoun, J., Kenn, W.: see Brekenfeld, C.
Schouman-Claeys, E.: Cerebrospinal fluid Kent, K. C.: see Wang, Y.
Galen, K. P.: see Wible, J. H., Jr. flow waveforms: MR analysis in chronic adult Kent, K. C.: see Wecksell, M. B.
Gaschen, L., Schuurman, H.-J.: Contribution of hydrocephalus, 146 Kessier, A.: see Metser, U.
power Doppler sonography to the detection of Hernandez, E. R.: see Rico, H. Khare, H. S.: see Di Bella, E. V. R.
renal allograft rejection in the Cynomolgus Heussel, C. P.: see Kauczor, H.-U. Khiat, A.: see Labelle, M.
monkey, 335 Hilgers, R.-D.: see Meyer, J. M. A. Kilig, D:. see Karadeniz, Y. M.
Gehl, H.-B.: see Brekenfeld, C. Hirohashi, S.: see Kuwatsuru, R. Kim, A. Y., Choi, B. I., Kim, T. K., Kim, K. W.,
George, M. S.: see Bohning, D. E. Hochmuth, A.: see Boehm, T. Lee, J. Y., Han, J. K.: Comparison of contrast-
Gerber, T. C., Schmermund, A., Reed, J. E.,
Hofman, A.: see Sijens, P. E. enhanced fundamental imaging, second-har-
Rumberger, J. A., Sheedy, P. F., Gibbons, Holmes, D. R.: see Gerber, T. C. monic imaging, and pulse-inversion harmonic
R. J., Holmes, D. R., Behrenbeck, T.: Use of Horlyck, A.: see Rawashdeh, Y. F. imaging, 582
a new myocardial centroid for measurement Hosten, N.: see Stroszezynski, C. Kim, H. J., Lee, C. H., Lee, S. H., Cho, B. M.,
of regional myocardial dysfunction by elec- Huetten, M.: see Meyer, J. M. A. Kim, H. K., Park, B. R., Ye, S. Y., Jeon, G. R.,
tron beam computed tomography: Compari- Hundt, W.: see Brekenfeld, C. Chang, K. H.: Early development of vaso-
son with technetium-99m sestamibi infarct Hutsebaut, J.: see Stolk, J. genic edema in experimental cerebral fat em-
size quantification, 193 Hyacinthe, R.: see Sayegh, Y. bolism in cats: Correlation with MRI and elec-
Gérvas, J. J.: see Rico, H. Hymphrey, M.: see Tello, R. tron microscopic findings, 460
Ghaye, B.: see Szapiro, D.
Hynes, M. R.: see Wible, J. H., Jr. Kim, H. K.: see Kim, H. J.
Gibbons, R. J.: see Gerber, T. C. Kim, K. W.: see Kim, A. Y.
Giesel, F. L.: see Knopp, M. V. Kim, S. A.: see Kwak, B. K.
Gilhuijs, K. G. A.: see Deurloo, E. E. Kim, T. K.: see Kim, A. Y.
Gillis, A., Bashir, A., McKeon, B., Scheller, A., Ibarra, R.: see Toney, G. M. Kirchin, M. A.: see Colosimo, C.; Katayama, H.
Gray, M. L., Burstein, D.: Magnetic resonance Idee, J.-M.: see Port, M. Kivelitz, D., Wagner, S., Hansel, J., Schnorr, J.,
imaging of relative glycosaminoglycan distri- Idée, J.-M.: see D’Anglemont De Tassigny Weitzler, R., Busch, M., Melzer, A., Taupitz,
bution in patients with autologous chondro- Idée, J.-M., Port, M., Robert, P., Raynal, I., M., Hamm, B.: The active magnetic resonance
cyte transplants, 743 Prigent, P., Dencausse, A., Le Greneur, S., imaging stent (AMRIS): Initial experimental
Glowinski, A.: see Haage, P. Tichkowsky, i., Le Lem, G., Bourrinet, P., in vivo results with locally amplified MR an-
Gogas, C.: see Papanikolaou, N. Mugel, T., Benderbous, S., Devoldere, L., giography and flow measurements, 625
Gonzalez, C. F.: see Runge, V. M. Bourbouze, R., Meyer, D., Bonnemain, B., Kleb, B.: see Rauch, D.
Gourtsoyiannis, N.: see Papanikolaou, N. Corot, C.: Preclinical profile of the monodis- Klose, K.-J.: see Rauch, D.
Gourtsoyiannis, N.: see Perisinakis, K. perse iodinated macromolecular blood pool Klose, K.-J.: see Wagner, H.-J.
Graif, M.: see Metser, U. agent P743, 41 Knilnani, N. M.: see Wang, Y.
Gray, M. L.: see Gillis, A. Idy-Peretti, I.: see Balédent, O. Knopp, M. V., Giesel, F. L., Radeleff, J., Von
Grimm, J.: see Miiller-Hiilsbeck, S. Idy-Peretti, I.: see Henry-Feugeas, M.-C. Tengg-Kobligk, H.: Bile-tagged 3D magnetic
Grimm, J., Miiller-Hiilsbeck, S., Heller, M.: Imazu, M.: see Tadehara, F. resonance colonography after exclusive intra-
Comparison of the mechanical thrombectomy Ishigami, K.: see Hatakenaka, M. venous administration of gadobenate dimeglu-
efficacy of the Amplatz thrombectomy device
mine, a contrast agent with partial hepatobili-
and the Cragg thrombolytic brush in vitro, 204 J ary excretion, 619
GGGGruuroleotlnstbtiseh,mr eagrAn,,. n :, GR .s.e TeT. W.:.: F: rs iseegesee e neKi D,aiM u ecVyzB.eeo lrrl,,a , JH.E. .-M U..V . A.R . JJJieanohknni,kn es,G, . TJ..R: . :R .s:es ee es eMei KiiTlmol,en re-yHH,.i iJlG.s. b ecMk., S. KKKooo,nn too,Yg .i aST.n.:n: isses,ee e TEaS.e:d oe,hs eaerT a.-,PS e.r iF.s inakis, K.
Giiney, S.: see Karadeniz, Y. M. Juergens, K.-U.: see Maintz, D. KKooorlv,e s,L . MJ..: S.s:e es eeC olDoesuirmloo,o, C.E. E.
GGiiiinntthheerr,, RR.. WW..:: sseeee HMaeaygeer,, PJ.. M. A. K KKorsacmiaenlnn,y , B.S.:: sseeee ULdaesrs,a u,M . N.
Giinther, R. W.: see Wildberger, J. E. Kadoya, M.: see Kuwatsuru, R. Krause, W., Mahler, M., Hanke, B., Milius, W.,
Kadrmas, D. J.: see Di Bella, E. V. R. Kaufmann, J., Rogalla, P.. Hamm, B.: Dy-
H Kaiser, W. A.: see Boehm, T. EOB-DTPA: Tolerance and pharmacokinetics
Kalinowski, M:. see Wagner, H.-J. in healthy volunteers and preliminary liver
Haage, P.: see Wildberger, J. E. Kalinowski, M.: see Tepe, G. imaging in patients, 431
Haage, P., Adam, G., Karaagac, S., Pfeffer, J., Kamenz, J.: see Tepe, G. Kreft, G.: see Bremer, C.
Glowinski, A., Déhmen, S., Giinther, R. W.: Kanal, E.: see Runge, V. M. Krombach, G.: see Meyer, J. M. A.
Mechanical delivery of aerosolized gadolini- Karaagac, S.: see Haage, P. Kugel, H.: see Maintz, D.
um-DTPA for pulmonary ventilation assess- Karadeniz, Y. M., Kilig, D., Altan, S. K., Alti- Kuhn, M. J.: see Runge, V. M.
ment in MR imaging, 240 nok, D., Giiney, $.: Evaluation of the role of Kurtz, C.: see Rauch, D. .
Halford, H. H.: see Runge, V. M. ultrasound machines as a source of nosoco- Kuwatsuru, R., Kadoya, M., Ohtomo, K., Tani-
Hamm, B.: see Kivelitz, D. mial and cross-infection, 554 moto, A., Hirohashi, S., Murakami, T.,
Hamm, B.: see Krause, W. Kataoka, Y.: see Tominaga, K. Tanaka, Y., Yoshikawa, K., Katayama, H.:
Han, J. K.: see Kim, A. Y. Katayama, H.: see Kuwatsuru, R. Comparison of gadobenate dimeglumine with
Hanisch, G.: see Kauczor, H.-U. Katayama, H., Heneine, N., Van Gessel, R., gadopentetate dimeglumine for magnetic res-
Hanke, B.: see Krause, W. Taroni, P., Spinazzi, A.: Clinical experience onance imaging of liver tumors, 632
Hanke, H.: see Tepe, G. with iomeprol in myelography and myelo-CT: Kwak, B. K., Shim, H. J., Park, E. S.. Kim, S. A.,
Hansel, J.: see Kivelitz, D. Clinical pharmacology and double-blind com- Choi, D., Lim, H. K., Park, C. K., Chung,
Hatakenaka, M., Ueda, M., Ishigami, K., Otsuka, parisons with iopamidol, iohexol, and iotro- J. W., Park, J. H.: Hepatocellular carcinoma:
M., Masuda, K.: Effects of aging on muscle lan, 22 Correlation between vascular endothelial
T2 relaxation time: Difference between fast- Katayama, H., Spinazzi, A., Fouillet, X., growth factor level and degree of enhance-
and slow-twitch muscles, 692 Kirchin, M. A., Taroni, P., Davies, A.: ment by multiphase contrast-enhanced com-
Heijboer, R. J. J.: see Sijens, P. E. lomeprol: Current and future profile of a ra- puted tomography, 487
Heindel, W.: see Maintz, D. diocontrast agent, 87
Heindel, W.: see Vieth, V. Kauczor, H.-U., Markstaller, K., Puderbach, M..,
L
Heller, M.: see Grimm, J. Lill, J., Eberle, B., Hanisch, G., Grossmann,
Heller, M.: see Miiller-Hiilsbeck, S. T., Heussel, C. P., Schreiber, W., Thelen, M.: Labelle, M., Khiat, A., Durocher, A., Boulanger,
Heneine, N.: see Katayama, H. Volumetry of ventilated airspaces by “He Y.: Comparison of metabolite levels and wa-
Henry-Feugeas, M.-C. C.: see Balédent, O. MRI: Preliminary results, 110 ter diffusion between cortical and subcortical
Henry-Feugeas, M.-C., Idy-Peretti, I., Baledent, Kaufmann, J.: see Krause, W. strokes as monitored by MRI and MRS, 155
No. 12 AUTHOR INDEX TO VOLUME 36
La Ferla, R.: see Colosimo, C. stent artifacts in three-dimensional MR an- Murakami, T.: see Kuwatsuru, R.
Lancelot, E.: see Port, M. giography, 218
Landwehr, P.: see Maintz, D. Majumdar, S.: see Vieth, V.
N
Langer, M.: see Winterer, J. T. Malich, A.: see Boehm, T.
Lassau, N., Koscielny, S., Opolon, P., De Baere, Manke, C.: see Strotzer, M. Nagel, S.: see Stroszezynski, C.
T., Peronneau, P., Leclere, J., Roche, A.: Mant, T. G. K.: see Bokor, D. Nahas, Z.: see Bohning, D. E.
Evaluation of constrast-enhanced color dopp- Mao, S., Budoff, M. J., Bakhsheshi, H., Liu, Natale, P. M.: see Weishaupt, D.
ler ultrasound for the quantification of angio- S. C. K.: Improved reproducibility of coro- Nazarian, L. N.: see Weishaupt, D.
genesis in vivo, 50 nary artery calcium scoring by electron beam Newitt, D.: see Vieth, V.
Laubenberger, J.: see Winterer, J. T. tomography with a new electrocardiographic Ni, Y., Adzamli, K., Miao, Y., Cresens, E., Yu,
Laurent, A.: see Pelage, J.-P. trigger method, 363 J., Periasamy, M. P., Adams, M. D., Marchal,
Laurent, S., Vander Elst, L., Copoix, F., Muller, Mao, S.-S.: see Lu, B. G.: MRI contrast enhancement of necrosis by
R. N.: Stability of MRI paramagnetic contrast Marchal, G.: see Ni, Y. MP-2269 and Gadophrin-2 in a rat model of
media: A proton relaxometric protocol for Maris, T.: see Papanikolaou, N. liver infarction, 97
transmetallation assessment, 115 Markkola, A. T., Aronen, H. J., Lukkarinen, S., Niizeki, M.: see Tominaga, K.
Lautrou, J.: see Port, M. Ramadan, U. A., Tanttu, J. 1, Sepponen, Nitz, W. R.: see Seitz, J.
Lazeyras, F.: see Sayegh, Y. R. E.: Multiple-slice spin lock imaging of Nosher, J. L.: see Snowhill, P. B.
Leclere, J.: see Lassau, N. head and neck tumors at 0.1 tesla: Exploring
Lee, C. H.: see Kim, H. J. appropriate imaging parameters with refer- O
Lee, D. H.: see Seo, T.-S. ence to T2-weighted spin-echo technique, 531
Lee, H. M.: see Wang, Y. Markstaller, K.: see Kauczor, H.-U. Oettle, H.: see Stroszcezynski, C.
Lee, J. Y.: see Kim, A. Y. Martel, A. L., Allder, S. J., Delay, G. S., Mor- Ogasawara, N.: see Suga, K.
Lee, S. H.: see Kim, H. J. gan, P. S., Moody, A. R.: Perfusion MRI of Ogasaware, N.: see Suga, K.
Le Greneur, S.: see Idée, J.-M. infarcted and noninfarcted brain tissue in Oh, J. H.: see Seo, T.-S.
Leike, J. U., Sachse, A., Rupp, K.: Characteriza- stroke: A comparison of conventional hemo- Ohtomo, K.: see Kuwatsuru, R.
tion of continuously extruded iopromide-car- dynamic imaging and factor analysis of dy- Oishi, R.: see Tominaga, K.
rying liposomes for computed tomography namic studies, 378 Okazaki, H.: see Suga, K.
blood-pool imaging, 303 Masuda, K.: see Hatakenaka, M. Opolon, P.: see Lassau, N.
Lejay, H.: see Henry-Feugeas, M.-C. Mathieu, J.: see Stolk, J. Otsuka, M.: see Hatakenaka, M.
Le Lem, G.: see Idée, J.-M. Matsunaga, N.: see Suga, K. Oudkerk, M.: see Sijens, P. E.
Lenhart, M.: see Seitz, J. McJames, S.: see Di Bella, E. V. R.
Lenhart, M.: see Strotzer, M. McKeon, B.: see Gillis, A. P
Levin, J. M.: see Runge, V. M. Mefiah, K.: see Dupas, B.
Lewin, M., Clément, O., Belguise-Valladier, P., Meiners, L. C., Scheffers, J. M., De Kort, Paez, E.: see Rico, H.
Tran, L., Cuénod, C.-A., Siauve, N., Frija, G.: G. A. P., Burger, H., Van Huffelen, A. C., Van Pahl, M. B.: see Uder, M.
Hepatocyte targeting with Gd-EOB-DTPA: Rijen, P. C., Van Veelen, C. W. M.: Curved Papanikolaou, N., Prassopoulos, P., Eracleous,
Potential application for gene therapy, 9 reconstructions versus three-dimensional sur- E., Maris, T., Gogas, C., Gourtsoyiannis, N.:
Licato, P.: see Schoenberg, S. O. face rendering in the demonstration of cortical Contrast-enhanced magnetic resonance
Lill, J.: see Kauczor, H.-U. lesions in patients with extratemporal epi- cholangiography versus heavily T2-weighted
Lim, H. K.: see Kwak, B. K. lepsy, 225 magnetic resonance cholangiography, 682
Link, T. M.: see Vieth, V. Meizer, A.: see Kivelitz, D. Park, B. R.: see Kim, H. J.
Liu, S. C. K. see Mao, S. Merland, J.-J.: see Pelage, J.-P. Park, C. K.: see Kwak, B. K.
Liu, S. C. K.: see Lu, B. Meszer, U., Friedman, Z., Even-Sapir, E., Sam- Park, E. S.: see Kwak, B. K.
Lodeann, K.-P.: see Brekenfeld, C. uels, D., Kessler, A., Graif, M.: Renal multi- Park, J. H.: see Kwak, B. K.
Lomarev, M. P.: see Bohning, D. E. gated spectral doppler imaging before and af- Pelage, J.-P., Laurent, A., Bonneau, M., Wassef,
Londy, F. J.: see Schoenberg, S. O. ter captopril challenge, 234 M., Rymer, R., Merland, J.-J.: Arterial blood
Lorusso, V.: see Frigeni, V. Meyer, D.: see Idée, J.-M. supply to the uterus in nonpregnant sheep: A
Lorusso, V., Taroni, P., Alvino, S., Spinazzi, A.: Meyer, D.: see Port, M. pe-tinent model for clinical practice?, 721
Pharmacokinetics and safety of iomeprol in Meyer, J. M. A., Buecker, A., Spuentrup, E., Periasamy, M. P.: see Ni, Y.
healthy volunteers and in patients with renal Schuermann, K., Huetten, M., Hilgers, R.-D., Periasamy, M. P.: see Wible, J. H., Jr.
impairment or end-stage renal disease requir- Van Vaals, J. J., Guenther, R. W.: Improved Perisinakis, K., Damilakis, J., Kontogiannis, E.,
ing hemodialysis, 309 in-stent magnetic resonance angiography with Gourtsoyiannis, N.: Film-screen magnifica-
Lotter, A:. see Vieth, V. high flip angle excitation: Technical note, 677 tion versus electronic magnification and en-
Low, R. N.: see Runge, V. M. Meyer, J. M. A., Schmitz-Rode, T., Krombach, hancement of digitized contact mammograms
G., Wildberger, J. E., Pfeffer, J., Giinther, in the assessment of subtle microcalcifica-
Lu, B., Mao, S.-S., Zhuang, N., Bakhsheshi, H..,
R. W.: Navi-ball: A new guidance device for tions, 726
Yamamoto, H., Takasu, J., Liu, S. C. K., Bu-
CT-directed punctures, 299 Peronneau, P.: see Lassau, N.
doff, M. J.: Coronary artery motion during the
Miao, Y.: see Ni, Y. Persigehl, T.: see Vieth, V.
cardiac cycle and optimal ECG triggering for
Mikawa, M.: see Suga, K. Pfeffer, J.: see Haage, P.
coronary artery imaging, 250
Milius, W.: see Krause, W. Pfeffer, J.: see Meyer, J. M. A.
Lukkarinen, S.: see Markkola, A. T.
Miragoli, L.: see Frigeni, V. Pianezzola, P.: see Colosimo, C.
Luzzani, F.: see Bokor, D.
Moesta, K. T.: see Stroszezynski, C. Pochon, S.: see Sayegh, Y.
Moody, A. R.: see Martel, A. L. Port, M.: see Idée, J.-M.
M Morgan, P. S.: see Martel, A. L. Port, M., Corot, C., Raynal, I., Idee, J.-M., Den-
Morrison, W. B.: see Weishaupt, D. causse, A., Lancelot, E., Meyer, D., Bonne-
MacDonald, J. R.: see Wible, J. H., Jr. Mortensen, J.: see Rawashdeh, Y. F. main, B., Lautrou, J.: Physicochemical and
Mahler, M.: see Krause, W. Mugel, T.: see Idée, J.-M. biological evaluation of P792, a rapid-clear-
Mahnken, A. H.: see Wildberger, J. E. Muller, R. N.: see Dupas, B. ance blood-pool agent for magnetic resonance
Maintz, D., Fischbach, R., Juergens, K.-U., Muller, R. N.: see Laurent, S. imaging, 445
Allkemper, T., Wessling, J., Heindel, W.: Muller, S. H. see Deurloo, E. E. Pradal, G.: see Dupas, B.
Multislice CT angiography of the iliac arteries Miiller-Hiilsbeck, S.: see Grimm, J. Prassopoulos, P.: see Papanikolaou, N.
in the presence of various stents: In vitro Miiller-Hiilsbeck, S., Brossmann, J., Jahnke, T., Prigent, P.: see Idée, J.-M.
evaluation of artifacts and lumen visibility, Grimm, J., Reuter, M., Bewig, B., Heller, M.: Prince, M. R.: see Wang, Y.
699 Mechanical thrombectomy of major and mas- Prince, M.R.: see Wecksell, M. B.
Maintz, D., Kugel, H., Schellhammer, F., Land- sive pulmonary embolism with use of the Am- Puderbach, M.: see Kauczor, H.-U.
wehr, P.: In vitro evaluation of intravascular platz thrombectomy device, 317 Puls, R.: see Stroszezynski, C.
INVESTIGATIVE RADIOLOGY December 2001 Vol. 36
R Schoenberg, S. O., Londy, F. J., Licato, P., Wil- Gd-DTPA-enhanced dynamic echo-planar
liams D. M., Wakefield, T., Chenevert, T. L.: MR imaging, 659
Radeleff, J.: see Knopp, M. V. Multiphase-multistep gadolinium-enhanced Suga, K., Ogasaware, N., Matsunaga, N., Sasai,
Ramadan, U. A.: see Markkola, A. T. MR angiography of the abdominal aorta and K.: Perfusion characteristics of oleic acid—
Rauch, D., Bohnemann, L., Kurtz, C., Drescher, runoff vessels, 283 Injured canine lung on Gd-DTPA-enhanced
P., Kleb, B., Klose, K.-J., Wagner, H. J.: Vas- Scholman, H. J.: see Stroszezynski, C. dynamic magnetic resonance imaging, 386
cular response to gadolinium-containing con- Schouman-Claeys, E.: see Henry-Feugeas, Sugimoto, J.: see Wasaki, M.
trast media in an ex vivo rabbit arterial model, M.-C. Szapiro, D., Ghaye, B., Willems, V., Zhang, L.,
589 Schreiber, W.: see Kauczor, H.-U. Albert, A., Dondelinger, R. F.: Evaluation of
Rawashdeh, Y. F., Hgrlyck, A., Mortensen, J., Schuermann, K.: see Meyer, J. M. A. CT time-density curves of lower-limb veins,
Frokiaer, J.: Short- and long-term repeatabil- Schuurman, H.-J.: see Gaschen, L. 164
ity of intrarenal resistive index in the pig, 341 Schweitzer, M. E.: see Weishaupt, D.
Rawool, N. M.: see Weishaupt, D. Seco, C.: see Rico, H. T
Raynal, L.: see Idée, J.-M.; Port, M. Seitz, J., Strotzer, M., Wild, T., Nitz, W. R.,
Reed, J. E.: see Gerber, T. C. Voélk, M., Lenhart, M., Feuerbach, S.: Quan- Tadehara, F., Imazu, M., Kono, S., Sano, K.:
Rees, P. J.: see Bokor, D. tification of blood flow in the carotid arteries: Calibration with currently available low-ra-
Reiber, J. H. C.: see Stolk, J. Cotaparison of Doppler ultrasound and three diopacity catheters for scaling in digital quan-
Reichenbach, J. R.: see Boehm, T. different phase-contrast magnetic resonance titative coronary angiography, 705
Reimer, P.: see Bremer, C. imaging sequences, 642 Takasu, J.: see Lu, B.
Resnick, D.: see Ertl-Wagner, B. B. Sendo, T.: see Tominaga, K. Tanaka, Y.: see Kuwatsuru, R.
Reuter, M.: see Miiller-Hiilsbeck, S. Seo, T.-S., Oh, J. H., Lee, D. H., Ko, Y. T., Tanenbaum, L. N.: see Runge, V. M.
Rico, H., Hernandez, E. R., Paez, E., Seco, C.., Yoon, Y.: Radiologic anatomy of the rabbit Tanimoto, A.: see Kuwatsuru, R.
Gérvas, J. J., Villa, L. F.: Do ultrasound mea- liver on hepatic venography, arteriography, Tanttu, J. I: see Markkola, A. T.
surements reflect bone microarchitecture portography, and cholangiography, 186 Taroni, P.: see Katayama, H.
rather than bone mass? An in vitro study of Sepponen, R. E.: see Markkola, A. T. Taroni, P.: see Lorusso, V.
the rat femur with the use of ultrasound, den- Shastri, A.: see Bohning, D. E. Tate, D. F.: see Bigler, E. D.
sitometry, and histomorphometry, 323 Sheedy, P. F.: see Gerber, T. C. Taupitz, M.: see Kivelitz, D.
Robert, P.: see Idée, J.-M Sherry, A. D.: see Zhang, S. Tello, R., Chaoui, A., Hymphrey, M., Fenlon,
Roche, A.: see Lassau, N. Shim, H. J.: see Kwak, B. K. H., Anastasia-Rubino, L., DeCarvalho, V. L.,
Rogalla, P.: see Krause, W. Shirota, K.: see Wasaki, M. Yucel, E. K.: Incidence of adrenal masses in
Roggan, A.: see Bremer, C. Siauve, N.: see Lewin, M. patients referred for renal artery stenosis
Rosendahl, U.: see Winterer, J. T. Siegel. R. L.: see Snowhill, P. B. screening MR, 518
Ross, S. G.: see Di Bella, E. V. R. Sijens, P. E., Den Heijer, T.. De Leeuw, F. E., Tepe, G., Duda, S. H., Kalinowski, M., Kamenz,
Rumberger, J. A.: see Gerber, T. C. De Groot, J. C., Achten, E., Heijboer, R. J. J., J., Brehme, U., Hanke, H., Claussen, C. D..
Runge, V. M.: A review of contrast media re- Hofman, A., Breteler, M. M. B., Oudkerk, M.: Bares, R., Baumbach, A., Dinkelborg, L. M.:
search in 1999-2000, 123 Human brain chemical shifte imaging at age Local intra-arterial drug delivery for preven-
Runge, V. M., Armstrong, M. R., Barr, R. G., 60 to 90: Analysis of the causes of the ob- tion of restenosis: Comparison of the effi-
Berger, B. L., Czervionke, L. F., Gonzalez, served sex differences in brain metabolites, ciency of delivery of different radiopharma-
C. F., Halford, H. H., Kanal, E., Kuhn, M. J., 597 ceuticals through a porous catheter, 245
Levin, J. M., Low, R. N., Tanenbaum, L. N., Silver, F. H.: see Snowhill, P. B. Terrier, F.: see Sayegh, Y.
Wang, A.-M., Wong, W., Yuh, W. T. C., Snowhill, P. B., Nosher, J. L., Seigel, R. L.. Thelen, M.: see Kauczor, H.-U.
Zoarski, G. H.: A clinical comparison of the Silver, F. H.: Characterization of radial forces Tichkowsky, I.: see Idée, J.-M.
safety and efficacy of MultiHance (gado- in Z stents, 521 Tominaga, K., Kataoka, Y., Sendo, T., Furuta,
benate dimeglumine) and Omniscan (gado- Spinazzi, A.: see Bokor, D. W.., Niizeki, M., Oishi, R.: Contrast medium-
daimide) in magnetic resonance imaging in Spinazzi, A.: see Katayama, H. induced pulmonary vascular hyperpermeabil-
patients with central nervous system pathol- Spinazzi, A.: see Lorusso, V. ity is aggravated in a rat climacterium model,
ogy, 65 Spuentrup, E.: see Meyer, J. M. A. 131
Runge, V. M.: Trends in contrast media re- Stibler, A.: see Ertl-Wagner, B. B. Toney, G. M., Chavez, H. A.. Ibarra, R., Jinkins,
search: Editorial, 688 Stargardt, A.: see Wildberger, J. E. J. R.: Acute and subacute physiological and
Rupp, K.: see Leike, J. U. Stoel, B. C.: see Stolk, J. histological studies of the central nervous sys-
Ruscalleda, J.: see Colosimo, C. Stolk, J., Dirksen, A., Van der Lugt, A., Hutse- tem after intrathecal gadolinium injection in
Rymer, R.: see Pelage, J.-P. baut, J.. Mathieu, J.. De Ree, J., Reiber, the anesthetized rat, 33
J. H. C., Stoel, B. C.: Repeatability of lung Tournier, H.: see Sayegh, Y.
S dpeuntseidt y tommoegarsauprheym enitns subwjietcht s lwoiwt-hd osa-e| -anctoimt-- TTrraanu,t weLi.:n , seeW .:L ewsiene , UdMe.r , M.
Sachse, A.: see Leike, J. U. rypsin deficiency—associated emphysema, 648 Trost, D. W.: see Wang, Y.
Samuels, D.: see Metser, U. Stroszezynski, C., Hosten, N., Puls, R., Nagel. Troup. C. M.: see Wible, J. H.. Jr.
Sano, K.: see Tadehara, F. S., Scholman, H. J., Wlodarezyk, W., Oettle, Trudell, D.: see Ertl-Wagner, B. B.
Sasai, K.: see Suga, K. H., Moesta, K. T., Schlag, P. M., Felix, R.: U
Sayegh, Y., Pochon, S., Vallée, J.-P... Becker, Histopathological correlation to MRI findings
M., Lazeyras, F., Tournier, H., Hyacinthe, R.. during and after laser-induced thermotherapy Uder, M., Utz, J.. Pahl, M. B., Schneider, G..,
Fouillet, X., Terrier, F.: Detection of experi- in a pig pancreas model, 413 Kramann, B., Trautwein, W.: lodinated radio-
mental hepatic tumors using long circulating Strotzer, M.: see Seitz, J. graphic contrast media inhibit the capacitative
superparamagnetic particles, 15 Strotzer, M., Lenhart, M., Butz, B., Vélk, M., entry of calcium into smooth muscle cells of
Schifer, O.: see Winterer, J. T. Manke, C., Feuerbach, S.: Appearance of vas- the swine renal artery, 734
Schaller, S.: see Wildberger, J. E. cular stents in computed tomographic angiog- Ueda. M.: see Hatakenaka, M.
Scheffers, J. M.: see Meiners, L. C. raphy: In vitro examination of 14 different Utz, J.: see Uder, M.
Scheffler, K.: see Winterer, J. T. stent types, 652
Scheller, A.: see Gillis, A. Suga, K., Mikawa, M., Ogasawara, N., Okazaki, Vv
Schellhammer, F.: see Maintz, D. H., Matsunaga, N.: Potential of Gd-DTPA-
Schlag, P. M.: see Stroszezyaski, C. Mannan liposome particles as a pulmonary Vallée, J.-P.: see Sayegh, Y.
Schmermund, A.: see Gerber, T. C. perfusion MRI contrast agent: An initial ani- Vander Elst, L.: see Laurent, S.
Schmitz-Rode, T.: see Meyer, J. M. A. mal study, 136 Van der Graaf, Y.: see Van Heesewijk, H. P. M.
Schmitz-Rode, T.: see Wildberger, J. E. Suga, K., Ogasawara, N., Okazaki, H., Sasai, K., Van der Lugt, A.: see Stolk, J.
Schneider, G.: see Uder, M. Matsunaga, N.: Functional assessment of ca- Van Gessel, R.: see Katayama, H.
Schnorr, J.: see Kivelitz, D. nine kidneys after acute vascular occlusion on Van Heesewijk, H. P. M., Casparie, H. W. B. M.,
No. 12 AUTHOR INDEX TO VOLUME 36
De Valois, J. C., Van Der Graaf, Y.: Effect of Wassef, M.: see Pelage, J.-P. Williams, D. M.: see Schoenberg, S. O.
dose levels on the diagnostic performance of a Watts, R.: see Wang, Y. Winchester, P. A.: see Wang, Y.
selenium-based digital chest system, 455 Wecksell, M. B., Winchester, P. A., Bush, H. L., Winchester, P. A.: see Wecksell, M. B.
Van Huffelen, A. C.: see Meiners, L. C. Jr., Kent, K. C., Prince, M. R., Wang, Y.: Winder, A. A.: see Weishaupt, D.
Van Rijen, P. C.: see Meiners, L. C. Cross-sectional pattern of collateral vessels in Winterer, J. T., Ennker, J., Scheffler, K., Rosen-
Van Vaals, J. J.: see Meyer, J. M. A. patients with superficial femoral artery occlu- dahl, U., Schafer, O., Wanner, M., Lauben-
Van Veelen, C. W. M.: see Meiners, L. C. sion, 422 berger, J., Langer, M.: Gadolinium-enhanced
Vieth, V., Link, T. M., Lotter, A., Persigehl, T., Weishaupt, D., Schweitzer, M. E., Rawool, elliptically reordered three-dimensional MR
Newitt, D., Heindel, W., Majumdar, S.: Does N. M., Nazarian, L. N., Morrison, W. B., angiography in the assessment of hand vascu-
the trabecular bone structure depicted by high- Natale, P. M., Winder, A. A.: Indirect MR larization before radial artery harvest for cor-
resolution MRI of the calcaneus reflect the arthrography of the knee: Effects of low-in- onary artery bypass grafting: first experience,
true bone structure?, 210 tensity ultrasound on the diffusion rate of in- 501
Villa, L. F.: see Rico, H. travenously administered Gd-DTPA in Wlodarezyk, W.: see Stroszezynski, C.
Violas, X.: see Wiart, M. healthy volunteers, 493 Wojdyla, J. K.: see Wible, J. H., Jr.
Volk, M.: see Seitz, J. Wessling, J.: see Maintz, D. Wong, W.: see Runge, V. M.
Volk, M.: see Strotzer, M. Wetzler, R.: see Kivelitz, D. Wool, C.: see Colosimo, C.
Von Tengg-Kobligk, H.: see Knopp, M. V. Wiart, M., Corot, C., Berthezene, Y., Violas, X., Wu, K.: see Zhang, S.
Canet, E.: CT pulmonary angiography with a Y
Ww macromolecular contrast medium: A compar-
ative study versus iobitridol in rabbits, 547 Yamamoto, H.: see Lu, B.
Wagner, H. J.: see Rauch, D. Wible, J. H., Jr., Galen, K. P., Wojdyla, J. K.: Yamashita, T.: Evaluation of the microangioar-
Wagner, H.-J., Kalinowski, M., Klose, K.-J., Cardiovascular effects caused by rapid admin- chitecture of tumors by use of monochromatic
Alfke, H.: The use of gadolinium chelates for istration of gadoversetamide injection in anes- x-rays, 713
x-ray digital subtraction angiography, 257 thetized dogs, 292 Ye, S. Y.: see Kim, H. J.
Wagner, S.: see Kivelitz, D. Wible, J. H., Jr.. Troup, C. M., Hynes, M. R., Yoon, Y.: see Seo, T.-S.
Wakefield, T.: see Schoenberg, S. O. Galen, K. P., MacDonald, J. R., Barco, S. J., Yoshikawa, K.: see Kuwatsuru, R.
Wang, A.-M.: see Runge, V. M. Wojdyla, J. K., Periasamy, M. P., Adams, Yu, J.: see Ni, Y.
Wang, Y.: see Wecksell, M. B. M. D.: Toxicological assessment of Gadover- Yucel, E. K.: see Tello, R.
Wang. Y., Winchester, P. A., Khilnani, N. M., setamide injection (OptiMARKa), a new con- Yuh, W. T. C.: see Runge, V. M.
Lee, H. M., Watts, R.. Trost, D. W., Bush, trast-enhancement agent for use in magnetic
H. L., Jr., Kent, K. G., Prince, M. R.: Con- resonance imaging, 401 Z
trast-enhanced peripheral MR angiography Wild, T.: see Seitz, J. Zhang, J.: see Duarte, C. G.
from the abdominal aorta to the pedal arteries: Wildberger, J. E.: see Meyer, J. M. A. Zhang, L.: see Szapiro, D.
Combined dynamic two-dimensional and bo- Wildberger, J. E., Mahnken, A. H., Schmitz- Zhang, S., Wu, K., Sherry A. D.: Gd** com-
lus-chase three-dimensional acquisitions, 170 Rode, T., Flohr, T., Stargardt, A., Haage, P.. plexes with slowly exchanging bound-water
Wanner, M.: see Winterer, J. T. Schaller, S., Giinther, R. W.: Individually molecules may offer advantages in the design
Wasaki, M., Sugimoto, J., Shirota, K.: Glucose adapted examination protocols for reduction of responsive MR agents, 82
alters the susceptibility of mesangial cells to of radiation exposure in chest CT, 604 Zhuang, N.: see Lu, B.
contrast media, 355 Willems, V.: see Szapiro, D. Zoarski, G. H.: see Runge, V. M.
Subject Index—Volume 36
blood-brain barrier, disruption in cerebral fat embolism (cat model), 460
blood flow velocities, in carotid arteries, 642
abdominal aorta blood-pool imaging, contrast agents fox
active MRI stent in, 625
iopromide-carrying liposomes for, 303
to pedal arteries, contrast-enhanced peripheral MRA of, 170 monodisperse iodinated macromolecular, 41
3D-Gd-MRA of, 283
versus iobitridol, 547
ablation rapid-clearance, 445
radiofrequency, of breast tumors (rabbit model), 480 bolus-chase 3D acquisitions, in abdominal aorta, 170
small LITT applicators for, 327 bone
active magnetic resonance imaging stent, 625 mineral density ultrasound measurements in (rat model), 323
Ad-SOS (amplitude-dependent speed of bone ultrasound), in rat, 323 structural measurement of, calcaneus specimens for, 210
adenoma, in renal artery stenosis screening, 518 brain
aging, effects on muscle T2 relaxation time, 692 chemical shift imaging in, 597
allograft rejection, renal, power Doppler sonography detecting, 335 chronic hydrocephalus of, MRI analysis in, 146
a-1-antitrypsin deficiency, in emphysema, lung density measurements contrast agents for MRI of, 266
and, 648 gadobenate dimeglumine and gadodiamide compared, 65
AMI-HS, hepatocyte-mediated transport of (rat model), 509 edema of, MRI and electron microscopy findings in (cat model), 460
Amplatz thrombectomy device, mechanical thrombectomy with perfusion imaging in stroke, 378
efficacy of, 204 brain ischemia, induced by MCA occlusion (rat models)
for pulmonary embolism, 317 EEG evaluation of, |
amplitude-dependent speed of bone ultrasound (rat model), 323 MRI of, 561
AMRIS (active magnetic resonance imaging stent), 625 brain volume, 539
anastomosis detection, between radial or ulnar artery supply, 501 breast
angiogenesis microcalcifications in, detection of, 726
quantification with contrast-enhanced Doppler ultrasound (murine stereotactic core biopsy of, 347
model), 50
tumors of
of VX2 tumors, monochromatic X-rays evaluating, 713 near-infrared optical mammography trials in, 573
angiography radiofrequency ablation in (rabbit model), 480
3D-Gd-enhanced
of abdominal aorta, 283 Cc
of hand for radial artery harvest, 501
digital. see digital angiography calcaneus specimens, high-resolution MRI and true bone structure, 210
hepatic (rabbit model), 186 calcium metabolism, in smooth muscle (porcine model), 734
pulmonary calibration, of catheter in quantitative coronary angiography, 705
iobitridol and P743 compared in, 547 captopril, simultaneous multigated spectral Doppler imaging and, 234
thrombus in, thrombectomy with Amplatz device for, 317 cardiovascular function, effect of gadoversetamide power injection on
angioplasty, transluminal, restenosis prevention and (rabbit model), 245 (canine model), 292
animal studies. see specific species carotid arteries, blood flow velocities in, 642
aorta. see abdominal aorta cat, vasogenic edema in cerebral fat embolism in, 460
applicator design, for LITT, 327 catheter calibration, in quantitative coronary angiography, 705
arteriography, in liver anatomy (rabbit model), 186 cellular rejection, power Doppler sonography detecting, 335
artery(ies) central nervous system
anatomy of, and blood supply in uterus (sheep model), 721 MRI of pathology affecting, 65
intra-arterial drug delivery for restenosis prevention (rabbit model), physiological and histological studies of (rat model), 33
245 cerebral blood flow, cerebrospinal fluid dynamics and, 368
radial, assessment for harvest of, 501 cerebral diseases, MRI in, 266
artifacts cerebrospinal fluid flow dynamics
in CT angiography, 652 and blood flow relationship, 368
of iliac arteries, 699 MRI analysis of, 146
intravascular stent, 3D-MRA evaluating, 218 chest CT, reducing radiation exposure in, 604
atherosclerosis, local drug delivery with radiopharmaceuticals in (rabbit cholangiography
model), 245 contrast-enhanced versus single-shot turbo spin-echo, 682
autologous chondrocyte transplants, MRI in, 743 in liver anatomy (rabvit model), 186
chondrocyte transplants, autoiogous, MRI in, 743
B chromatography profile, of P743, 41
chronic obstructive pulmonary disease, SonoVue™ safety testing in, 104
bile duct radiography (rabbit model), 186 cine MRI, cerebrospinal fluid dynamics study with, 368
biliary excretion, of AMI-HS (rat model), 509 climacterium, contrast medium-induced pulmonary vascular
biliary tree, 3D-imaging comparisons in, 682 hyperpermeability in (rat model), 131
biocompatibility, of P792, 445 collateral pattern, in occluded superficial artery, 422
biopsy color Doppler ultrasonography, for angiogenesis quantification (murine
Navi-ball for CT in, 299 model), 50
Stereotactic, in breast, 347 computed tomographic angiography
754
No. 12 INDEX TO VOLUME 36
appearance of vascular stents in, 652 D
multislice, of iliac arteries, 699
dementia, intracranial volume measurement to assess, 539
pulmonary, with P743 contrast medium, 547
densitometry, in vitro femur study (rat model), 323
3D, intravascular, 218
depression, vagus nerve stimulation for, 470
computed tomography
diabetic patients, contrast media-induced nephropathy in, 355
artifacts on, vascular stents causing, 652
dialysis fistulas, mechanical thrombectomy for, 204
blood-pool agents for, 303
diffusion-weighted MRI, in cortical and subcortical stroke, 155
of chest, reducing radiation exposure in, 604 digital angiography
for coronary artery screening, 250 catheter calibration in, 705
directed punctures in, Navi-ball for, 299 use of Gd chelates for, 257
electron beam. see electron beam tomography digital chest system, selenium-based, 455
of hepatocellular carcinoma, 487 digitization, of contact mammograms, 659
of liver, 487 dog
after Dy-EOB-DTPA injection, 431 dynamic SPECT with °°™Tc teboroxime versus static thallium-201 in
of lower limb veins, 164 (canine model), 178
multislice, lung density measurements with, 648 gadoversetamide injection in, cardiovascular effects of, 292
single-photon emission, with ”’"TC-labeled teboroxime (canine kidney assessment with dynamic EPI in, 659
model), 178 Doppler ultrasonography
computer-aided diagnosis, in contact mammography, 659 in carotid artery blood flow velocity assessment, 642
contamination, ultrasonography probes and, 554 color contrast-enhanced, for angiogenesis quantification (murine
contrast agents. see also individual agents model), 50
for blood-pool imaging. see blood-pool imaging, contrast agents for for hypertension detection, 234
in cerebral disease imaging, clinical dose for, 266 intrarenal resistive index repeatability and (porcine model), 341
in CT vascular studies, 164 of knee, 493
for hepatocellular carcinoma imaging, 487 for renal artery stenosis, 234
hepatocyte-mediated transport of (rat model), 509 renal multigated spectral, 234
iodinated. see iodinated contrast media for renal transplant evaluation, 335
iron oxide-based, for liver tumor detection (rabbit model), 15 for vasculopathy detection, 335
liver-specitic DSA (digital subtraction angiography), Gd chelates in, 257
Dy-EOB-DTPA, 431 dual-energy X-ray absorptionmetry, for bone mineral content and
Gd-EOB-DTPA. 9 density determination (rat model), 323
nephropathy induced by, 355 Dy-EOB-DTPA, liver imaging and, 431
for optical mammography, 573 dynamic _— emission computed tomography (canine model),
sia relaxometric protocol for transmetallation assessment, dysprosium-EOB-DTPA, liver imaging and, 431
in peripheral MRA, 170 E
pH-sensitive, 82
pulmonary vascular hyperpermeability induced by (rat model), 131 EBT. see electron beam tomography
in rat models ECG. see electrocardiography
gadobenate dimeglumine versus gadobutrol, 561 ig peat Gd-DTPA-enhanced, of kidneys (canine
male hypertensive, kidney toxicity in, 56 model), 65
MP-2269 and gadophrin use in, 97 edema . oe
nourctsherebiiiey of. 1 cerebral, MRI and electron microscopy findings in (cat model), 460
canine wns oy 123. 688 pulmonary, contrast medium-induced (rat model), 131
SonoVue™ safety and, 104 cane. ae Copegge Fa
for time-density curves of lower-limb veins, 164 omy ae mn ener remem — _
: et) ie electrocardiography, and coronary imaging, 250
oe Say SEA, 357 improved reproducibility with EBT and, 363
contrast enhancement
electroencephalogram, and contrast agent neurotolerability in brain
for angiogenesis quantification (murine model), 50
ischemia (rat model), |
in MR cholangiography, single-shot turbo spin-echo technique versus, electron beam tomography
682
improving interscan reproducibility with, 363
versus second-harmonic and pulse-inversion imaging, 582 for myocardial dysfunction measurement, 193
COPD (chronic obstructive pulmonary disease), SonoVue™ safety electron microscopy, of brain edema and fat embolism (cat model), 460
testing in, 104 electrospray ionization-mass spectrometry, of P743, 41
coronary artery imaging elimination, of iopromide-carrying liposomes, 303
calcification quantification with EBT, 363 embolism, cerebral fat, MRI and electron microscopy findings in (cat
in cardiac cycle, 250 model), 460
cortical lesions, in extratemporal epilepsy, 225 emphysema, MSCT lung density measurements in, 648
Cragg thrombolytic brush, 204 endoscopy, virtual, intraluminal contrast enhancement in, 619
cross-infection, ultrasonography probes and, 554 endothelin, mediating renal effects of contrast administration (rat
CT. see computed tomography model), 56
CTA. see computed tomographic angiography EPI (echo-planar imaging), dynamic Gd-DTPA-enhanced, of kidneys
curved reconstructions, in epileptic cortical lesions, 225 (canine model), 659
INVESTIGATIVE RADIOLOGY December 2001 Vol. 36
epilepsy ‘He MRI, for volumetry of ventilated airpsaces, 110
extratemporal, cortical lesion demonstrations in, 225 head and neck tumors, 531
vagus nerve stimulation for, 470 heart, optimal ECG triggering for coronary artery imaging and, 250
estradiol, pulmonary vascular hyperpermeability induced by (rat model), hemodialysis patients, pharmacokinetics and safety of iomeprol in, 309
131 hemodynamic imaging, of brain tissue in stroke patients, 378
extratemporal epilepsy, cortical lesion demonstrations in, 225 hepatic angiography (rabbit model), 186
F hepatobiliary MRI contrast agent, 9
in cholangiography, 682
factor analysis, for perfusion-weighted images, 378 in colonography, 619
femur, ultrasound in vitro study of (rat model), 323 hepatocellular carcinoma
flip angles, stents and MRA and, 677 CT of, 487
flow dynamics, in carotid arteries, measurement techniques compared, gene therapy study for, 9
642 hepatocytes
fMRI (functional magnetic resonance imaging) AMI-HS transport mediated by (rat model), 509
of synchronized vagus nerve stimulation, 470 Gd-EOB-DTPA targeting, 9
herpes virus thymidine-kinase gene, 9
G high-resolution MRI, for trabecular bone structure, 210
hippocampal volume, 539
gadobenate dimegiumine
histomorphometry, femoral (rat model), 323
in central nervous system pathology, safety and efficacy of, 65
hydrocephalous, chronic adult, MRI analysis of, 146
in colonography, 619
hyperpolarization, 110
in EEG evaluation (rat model), |
hypertension
gadobutrol versus (rat model), 561
kidney toxicity studies of radiocontrast media in (rat model), 56
in intracranial metastases detection, 72
renal artery stenosis screening in, 518
gadobutrol, versus gadobenate dimeglumine (rat model), 561
renovascular, simultaneous multigated spectral Doppler imaging for,
gadodiamide, safety and efficacy of, 65
234
gadolinium
cardiovascular effects of (canine model), 292
in central nervous system pathology, safety and efficacy of, 65
in MRA
of abdominal aorta and run-off vessels, 283 infection, ultrasonography probes and, 554
of hand for radial artery harvest, 501 interventional radiology
transmetallation study of, 115 Amplatz thrombectomy device and Cragg thrombolytic brush efficacy
vascular response to (rabbit model), 589 and, 204
for X-ray DSA, 257 uterine blood supply and (sheep model), 721
gadolinium-diethylenetriaminepenta-acetic acid. see Gd-DTPA intracranial volume, 539
gadopentate, arterial response to (rabbit model), 589 intraluminal contrast enhancement, in virtual endoscopy, 619
gadopentetate dimeglumine, in CNS studies after intrathecal injection intrathecal contrast administration (rat model), 33
(rat model), 33 iobitridol, P743 versus, 547
gadophrin-2 contrast enhancement, of necrotic liver infarction (rat iodinated contrast media
model), 97 ionic and nonionic, effects on platelet function, 276
gadoteridol, arterial response to (rabbit model), 589 radiographic, caicium metabolism in smooth muscle cells and (porcine
gadoversetamide injection model), 734
cardiovascular effects of (canine model), 292 iodixanol, antiplatelet effect of, 276
toxicological assessment of, 401 iohexol
Gd chelates, for X-ray DSA, 257 antiplatelet effect of, 276
Gd-DTPA versus iomeprol, in myelography and myelo-CT, 22
aerosolized, for pulmonary ventilation assessment, 240 iomeprol
in enhanced dynamic EPI of kidneys (canine model), 659 effects on calcium metabolism in smooth muscle (porcine model), 734
mannan-coated liposome particles, pulmonary perfusion and, 136 in myelography and myelo-CT, 22
for MR arthrography of knee, 493 pharmacokinetics and safety of, 309
in oleic acid-injured lung imaging (canine model), 386 profile of, 87
in transmetallation study, 115 ionic contrast media, and platelet function, 276
Gd-EOB-DTPA, hepatocyte targeting with, 9 iopamidol, in myelography and myelo-CT, 22
gel permeation chromatography profile, of P743, 41 iopromide-carrying liposomes, for CT blood-pool imaging, 303
gene therapy iotroian, in myelography and myelo-CT, 22
for hepatocellular carcinoma, 9 ioxaglate, antiplatelet effect of, 276
for superficial femoral artery occlusion, 422
glucose-altered contrast susceptibility, of mesangial cells K
glycosaminoglycan distribution. in autologous chondrocyte transplant
patients, 743 kidney. see also renal entries
H damage to, radiocontrast media-induced (rat model), 56
function, Gd-DTPA-enhanced dynamic EPI assessment of, 659
hand, MRA for radial artery harvest in, 501 and intrarenal resistive index repeatability (porcine model), 341
harmonic imaging, 582 radiocontrast media toxicity in (rat model), 56
No. 12 INDEX TO VOLUME 36
renal artery stenosis and. see renal artery stenosis in extratemporal epilepsy, 225
knee, indirect MR arthrography of, 493 of head and neck tumors, 531
of hepatic tumors (rabbit model), 15
L high-resolution, for trabecular bone structure, 210
in hydrocephalus, 146
lanthanide DOTA-tetraamide derivatives, 82 of lung
laser-induced thermotherapy in oleic acid-induced injury, 386
histopathological versus MRI correlations in (porcine model), 413 for pulmonary ventilation assessment, 240
interstitial, evaluation of, 327 in volumetry of ventilated airspaces, 110
laser mammography, optical contrast medium for, 573 in necrotic liver infarction (rat model), 97
liposomes rapid-clearance blood-pool agent for, 445
iopromide-carrying, for CT blood-pool imaging, 303 in renal artery stenosis screening, 519
mannan-coated, for pulmonary perfusion, 136 in stroke patients, 155
L: ITT. see laser-induced thermotherapy hemodynamic versus dynamic, 378
liver of thermal effects in LITT, 327
angiography in (rabbit model), 186 in porcine model, 413
cT of, 487 magnetic resonance procedures, health effects and safety of, book
after Dy-EOB-DTPA injection, 431 review, 500 ,
experimental tumors of (rabbit model), 15 magnetic resonance spectroscopy
cmt infarction = ont model), 7 : ; . of human brain, chemical shift in, 597
long circulating superparamagnetic particles, for hepatic tumor detection in stroke patients, 155
(rabbit model), 1S mammography
low-field MRI, in cerebral diseases, contrast agent dosage for, 266 for mlemnedictiection detection, 726
low radiopacity, in quantitative coronary angiography, 705 near-infrared optical, contrast medium for, 573
lung. see also pulmonary entries
mannan-coated liposomes, pulmonary perfusion and, 136
angiography of, iobitridol versus P743 in, 547
mannitol, and renal failure (rat model), 56
edema in, contrast medium-induced (rat model), 131
MCA. see middle cerebral artery
embolism in, thrombectomy with Amplatz device for, 317
mechanical thrombectomy, with Amplatz thrombectomy device
injury to, Gd-DTP A-enhanced MRI perfusion characteristics in, 386
efficacy of, 204
MSCT density measurements in, 648
for pulmonary embolism, 317
and selenium-based digital chest system, 455
meglumine hydrochloride, membrane closure time and, 276
ventilation assessment, aerosolized Gd-DTPA MRI for, 240
membrane closure time, effects of ionic and nonionic iodinated low-
lung disease, volumetry of ventilated airspaces in, 110
osmolar contrast media on, 276
mesangial cells, glucose-altered contrast susceptibility of, 355
M
metabolism
magnetic resonance angiography of brain in elderly population, 597
artifact free imaging, measurement with, 625 of calcium, in smooth muscle (porcine model), 734
digital subtraction, 170 metabolite levels, in cortical and subcortical stroke, 155
gadolinium-enhanced metalloporphyrins, 97
of abdominal aorta and runoff vessels, 283 microangioarchitecture, of VX2 tumors, 713
of hand for radial artery harvest. 501 microbubble agents, SonoVue™ and, 104
peripheral, from abdominal aorta to pedal arteries, contrast-enhanced, microcalcifications, in breast, 726
170 middle cerebral artery occlusion, contrast agents in imaging of (rat
stents in, varying flip angles with, 677 models)
3D. intravascular stent artifact evaluation in, 218 gadobenate dimeglumine versus gadobutrol (rat model), 561
magnetic resonance arthrography, of knee, 493 neurotolerability of, |
magnetic resonance cholangiography, contrast-enhanced, versus single- monochromatic X-rays, of VX2 tumors, 713
shot turbo spin-echo, 682 monodisperse iodinated macromolecular blood pool agents, preclinical
magnetic resonance imaging profiles of, 41
AMI-HS contrast agent for, biliary excretion of (rat model), 509 mouse tumor model, contrast-enhanced color Doppler ultrasound in, 50
of aorta, stent evaluation in, 625 MP-2269 contrast enhancement, of necrotic liver infarction (rat model),
of autologous chondrocyte transplants, 743 97
of brain MRA. see magnetic resonance angiography
in adult chronic hydrocephalus, 146 MRI. see magnetic resonance imaging
chemical shift in, 597 MSCT. see multislice computed tomography
dosage of contrast agents for, 266 MultiHance, 72. see also gadobenate dimeglumine
edema and fat embolism in (cat model), 460 multiple-slice SL-GRE sequences, for head and neck tumor imaging,
gadobenate dimeglumine verus gadodiamide for, 65 531
intracranial volume and dementia and, 539 multislice computed tomography
in carotid artery blood flow velocity, 642 of iliac arteries, 699
of cerebrospinal fluid dynamics, 368 lung density measurements with, 648
of colon, 619 muscle, T2 relaxation time in, effects of aging on, 692
contrast agents for. see contrast agents; individual agents myelography, iomeprol versus iotrolan in, 22
echo-planar. see echo-planar imaging myocardium
758 INVESTIGATIVE RADIOLOGY December 2001 Vol. 36
infarction of, EBT measurement in, 193 for renal transplant evaluation, 335
SPECT assessment of (canine model), 178 prostheses, 3D-MRA evaluating, 218
proton relaxometric protocol, for transmetallation assessment, 115
N pulmonary function test, and “He MRI, 110
pulmonary perfusion
Navi-ball, for CT-directed punctures, 299
Gd-DTP A-enhanced MRI characteristics in lung injury, 386
near-infrared optical mammography, contrast medium for, 573
MRI contrast agent for, 136
neck and head tumor imaging, 531
pulse-inversion harmonic imaging, 582
necrosis, in liver infarction (rat model), 97
needle deviations, during stereotactic procedures in breast, 347 Q
neoplasms
of breast, stereotactic core biopsy of, 347 quantitative coronary angiography, low radiopacity catheters in, 705
of liver. see hepatocellular carcinoma
neurotolerability, of contrast agents, EEG evaluation of (rat model), 1 R
nonionic contrast media, and platelet function, 276
rabbit
nonproton MRI, 110
experimental hepatic tumors in, 15
nosocomial infection, ultrasonography probes and, 554
liver in, radiologic anatomy of, 186
nuclear medicine
and ”’™TC-labeled teboroxime modeling with dynamic SPECT local drug delivery with radiopharmaceuticals in (rabbit model), 245
vascular response to gadolinium-containing MRI contrast media in,
(canine model), 178
589
in myocardial dysfunction measurement, 193
VX2 tumors in, radiofrequency ablation of, 480
radial artery harvest, contrast-enhanced 3D-MRA for, 501
O
radial force, in Z stents, 521
oleic acid-injured lung, perfusion characteristics of (canine model), 386 radiation exposure
Omniscan, 65 in chest CT, reduction of, 604
online monitoring, of thermal ablation techniques (porcine model), 413 in mammography, 726
osteoporosis, trabecular bone structure and, 210 radiofrequency ablation, of VX2 tumors (rabbit model), 480
ovarian artery (sheep model), 721 radiopacity, in quantitative coronary angiography, 705
oxidative stress, mesangial cells and, 355 radiopharmaceuticals, local drug delivery with (rabbit model), 245
rapid-clearance blood-pool agent, in MRI, 445
P RAS. see renal artery stenosis
rat
P743
biliary excretion of AMI-HS in (rat model), 509
versus iobitridol, 547
central nervous system studies in, 33
preclinical profile of, 41
climacterium model, induced vascular hyperpermeability in, 131
P792, in MRI, 445
contrast agents for brain ischemia imaging in
P41743, preclinical profile of, 41
MR agents compared (rat model), 561
pancreas, LITT for (porcine model), 413
neurotolerability of, 1
paramagnetic contrast media, in transmetallation assessment, 115
femur in, ultrasound in vitro study of, 323
perfusion imaging
hypertensive male, radiocontrast media kidney toxicity in, 56
of brain tissue in stroke patients, 378
liver infarction model in, 97
in lung. see pulmonary perfusion
rejection, renal allograft, power Doppler sonography detecting, 335
vascular response to gadolinium-containing contrast media in (rabbit
relaxation times, in SL-GRE sequence measurements, 531
model), 589
relaxivity, of P792, 445
peripheral vascular disease
relaxometry
3D-MRA for collateral vessel location in, 422
Gd-EOB-DTPA quantification with, 9
MRA for, 170
proton protocol for transmetallation assessment, 115
PFA-100™ (platelet function analyzer), 276
renal artery stenosis
pH-sensitive contrast agents, 82
MR screening for, 518
pharmacokinetics
simultaneous multigated spectral Doppler imaging for, 234
of iomeprol, 309
renal disorders, iomeprol use in, pharmacokinetics and safety of, 309
of iopromide-carrying liposomes, 303
renal transplants, power Doppler sonography evaluating, 335
of P792, 445
resistive index
phase imaging, of carotid artery blood flow, 642
intrarenal, repeatability of (porcine model), 341
pig
in renal artery stenosis evaluation, 234
calcium metabolism and X-ray contrast media in renal artery of, 734
restenosis, prevention of, intra-arterial drug delivery for (rabbit model),
intrarenal resistive index in, 341 245
pancreas in, histopathological versus MRI correlation in LITT for,
Rotterdam Study, 597
413
platelets, effects of ionic and nonionic iodinated contrast media on, 276
polyethyleneimine Gd-EOB-DTPA, 9
polylysine Gd-EOB-DTPA, 9 safety testing
portography, in liver anatomy (rabbit model), 186 of iomeprol, 309
power Doppler sonography of SonoVue™, 104
of knee, 493 scintigraphy